ID   M4K2_HUMAN              Reviewed;         820 AA.
AC   Q12851; Q86VU3;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   10-MAY-2017, entry version 166.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase kinase 2;
DE            EC=2.7.11.1;
DE   AltName: Full=B lymphocyte serine/threonine-protein kinase;
DE   AltName: Full=Germinal center kinase;
DE            Short=GC kinase;
DE   AltName: Full=MAPK/ERK kinase kinase kinase 2;
DE            Short=MEK kinase kinase 2;
DE            Short=MEKKK 2;
DE   AltName: Full=Rab8-interacting protein;
GN   Name=MAP4K2; Synonyms=GCK, RAB8IP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAA20968.1};
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2-820 (ISOFORM 1), FUNCTION, DOMAIN, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Tonsil;
RX   PubMed=7515885;
RA   Katz P., Whalen G., Kehrl J.H.;
RT   "Differential expression of a novel protein kinase in human B
RT   lymphocytes. Preferential localization in the germinal center.";
RL   J. Biol. Chem. 269:16802-16809(1994).
RN   [5]
RP   FUNCTION, AND ENZYME REGULATION.
RX   PubMed=7477268; DOI=10.1038/377750a0;
RA   Pombo C.M., Kehrl J.H., Sanchez I., Katz P., Avruch J., Zon L.I.,
RA   Woodgett J.R., Force T., Kyriakis J.M.;
RT   "Activation of the SAPK pathway by the human STE20 homologue germinal
RT   centre kinase.";
RL   Nature 377:750-754(1995).
RN   [6]
RP   FUNCTION, AUTOPHOSPHORYLATION, AND INTERACTION WITH MAP3K1/MEKK1 AND
RP   TRAF2.
RX   PubMed=9712898; DOI=10.1074/jbc.273.35.22681;
RA   Yuasa T., Ohno S., Kehrl J.H., Kyriakis J.M.;
RT   "Tumor necrosis factor signaling to stress-activated protein kinase
RT   (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase
RT   couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1
RT   and SAPK while receptor interacting protein associates with a mitogen-
RT   activated protein kinase kinase kinase upstream of MKK6 and p38.";
RL   J. Biol. Chem. 273:22681-22692(1998).
RN   [7] {ECO:0000305}
RP   FUNCTION, AND INTERACTION WITH TRAF2 AND MAP3K1.
RX   PubMed=11784851; DOI=10.1128/MCB.22.3.737-749.2002;
RA   Chadee D.N., Yuasa T., Kyriakis J.M.;
RT   "Direct activation of mitogen-activated protein kinase kinase kinase
RT   MEKK1 by the Ste20p homologue GCK and the adapter protein TRAF2.";
RL   Mol. Cell. Biol. 22:737-749(2002).
RN   [8]
RP   ENZYME REGULATION, FUNCTION, UBIQUITINATION, AND INTERACTION WITH
RP   TRAF6.
RX   PubMed=15456887; DOI=10.1128/MCB.24.20.9165-9175.2004;
RA   Zhong J., Kyriakis J.M.;
RT   "Germinal center kinase is required for optimal Jun N-terminal kinase
RT   activation by Toll-like receptor agonists and is regulated by the
RT   ubiquitin proteasome system and agonist-induced, TRAF6-dependent
RT   stabilization.";
RL   Mol. Cell. Biol. 24:9165-9175(2004).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH MAP3K11/MLK3.
RX   PubMed=17584736; DOI=10.1074/jbc.M703422200;
RA   Zhong J., Kyriakis J.M.;
RT   "Dissection of a signaling pathway by which pathogen-associated
RT   molecular patterns recruit the JNK and p38 MAPKs and trigger cytokine
RT   release.";
RL   J. Biol. Chem. 282:24246-24254(2007).
RN   [10]
RP   REVIEW ON FUNCTION.
RX   PubMed=10026130; DOI=10.1074/jbc.274.9.5259;
RA   Kyriakis J.M.;
RT   "Signaling by the germinal center kinase family of protein kinases.";
RL   J. Biol. Chem. 274:5259-5262(1999).
RN   [11]
RP   REVIEW ON FUNCTION.
RX   PubMed=11316611; DOI=10.1016/S0962-8924(01)01980-8;
RA   Dan I., Watanabe N.M., Kusumi A.;
RT   "The Ste20 group kinases as regulators of MAP kinase cascades.";
RL   Trends Cell Biol. 11:220-230(2001).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-394, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-394, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-394, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328 AND SER-394, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Serine/threonine-protein kinase which acts as an
CC       essential component of the MAP kinase signal transduction pathway.
CC       Acts as a MAPK kinase kinase kinase (MAP4K) and is an upstream
CC       activator of the stress-activated protein kinase/c-Jun N-terminal
CC       kinase (SAP/JNK) signaling pathway and to a lesser extent of the
CC       p38 MAPKs signaling pathway. Required for the efficient activation
CC       of JNKs by TRAF6-dependent stimuli, including pathogen-associated
CC       molecular patterns (PAMPs) such as polyinosine-polycytidine
CC       (poly(IC)), lipopolysaccharides (LPS), lipid A, peptidoglycan
CC       (PGN), or bacterial flagellin. To a lesser degree, IL-1 and
CC       engagement of CD40 also stimulate MAP4K2-mediated JNKs activation.
CC       The requirement for MAP4K2/GCK is most pronounced for LPS
CC       signaling, and extends to LPS stimulation of c-Jun phosphorylation
CC       and induction of IL-8. Enhances MAP3K1 oligomerization, which may
CC       relieve N-terminal mediated MAP3K1 autoinhibition and lead to
CC       activation following autophosphorylation. Mediates also the
CC       SAP/JNK signaling pathway and the p38 MAPKs signaling pathway
CC       through activation of the MAP3Ks MAP3K10/MLK2 and MAP3K11/MLK3.
CC       May play a role in the regulation of vesicle targeting or fusion.
CC       regulation of vesicle targeting or fusion.
CC       {ECO:0000269|PubMed:11784851, ECO:0000269|PubMed:15456887,
CC       ECO:0000269|PubMed:17584736, ECO:0000269|PubMed:7477268,
CC       ECO:0000269|PubMed:7515885, ECO:0000269|PubMed:9712898}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:7515885}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:7515885};
CC   -!- ENZYME REGULATION: The tumor necrosis factor (TNF), as well as
CC       endotoxins and proinflammatory stimuli such as polyinosine-
CC       polycytidine (poly(IC)), lipopolysaccharides (LPS), peptidoglycan
CC       (PGN), flagellin, or lipid A activate MAP4K2 by promoting its
CC       autophosphorylation. {ECO:0000269|PubMed:15456887,
CC       ECO:0000269|PubMed:7477268}.
CC   -!- SUBUNIT: Interacts with TRAF2, TRAF6, MAP3K1/MEKK1 and
CC       MAP3K11/MLK3. Interacts with RAB8A (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q13233:MAP3K1; NbExp=2; IntAct=EBI-49783, EBI-49776;
CC       Q9NUX5:POT1; NbExp=2; IntAct=EBI-49783, EBI-752420;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Basolateral cell
CC       membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.
CC       Golgi apparatus membrane {ECO:0000250}; Peripheral membrane
CC       protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q12851-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q12851-2; Sequence=VSP_054134;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in germinal center but not
CC       mantle zone B-cells. Also expressed in lung, brain and placenta
CC       and at lower levels in other tissues examined.
CC       {ECO:0000269|PubMed:7515885}.
CC   -!- DOMAIN: The PEST domains are Pro-, Glu-, Ser-, and Thr-rich
CC       domains. Proteins with PEST domains are frequently targets of
CC       degradation by the ubiquitin proteasome.
CC       {ECO:0000269|PubMed:7515885}.
CC   -!- PTM: Polyubiquitinated through 'Lys-48'-polyubiquitin chains,
CC       allowing proteasomal turnover. Ubiquitination requires the kinase
CC       activity of MAP4K2/GCK. {ECO:0000269|PubMed:15456887}.
CC   -!- PTM: Autophosphorylated in response to tumor necrosis factor
CC       (TNF), endotoxins or proinflammatory stimuli. Autophosphorylation
CC       leads to activation.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA20968.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP001462; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471076; EAW74302.1; -; Genomic_DNA.
DR   EMBL; BC047865; AAH47865.1; -; mRNA.
DR   EMBL; U07349; AAA20968.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS8082.1; -. [Q12851-1]
DR   CCDS; CCDS81582.1; -. [Q12851-2]
DR   PIR; A53714; A53714.
DR   RefSeq; NP_001294919.1; NM_001307990.1. [Q12851-2]
DR   RefSeq; NP_004570.2; NM_004579.4. [Q12851-1]
DR   UniGene; Hs.534341; -.
DR   ProteinModelPortal; Q12851; -.
DR   SMR; Q12851; -.
DR   BioGrid; 111809; 15.
DR   IntAct; Q12851; 14.
DR   MINT; MINT-8247528; -.
DR   STRING; 9606.ENSP00000294066; -.
DR   BindingDB; Q12851; -.
DR   ChEMBL; CHEMBL5330; -.
DR   GuidetoPHARMACOLOGY; 2086; -.
DR   iPTMnet; Q12851; -.
DR   PhosphoSitePlus; Q12851; -.
DR   BioMuta; MAP4K2; -.
DR   DMDM; 215274019; -.
DR   EPD; Q12851; -.
DR   MaxQB; Q12851; -.
DR   PaxDb; Q12851; -.
DR   PeptideAtlas; Q12851; -.
DR   PRIDE; Q12851; -.
DR   DNASU; 5871; -.
DR   Ensembl; ENST00000294066; ENSP00000294066; ENSG00000168067. [Q12851-1]
DR   Ensembl; ENST00000377350; ENSP00000366567; ENSG00000168067. [Q12851-2]
DR   GeneID; 5871; -.
DR   KEGG; hsa:5871; -.
DR   UCSC; uc001obh.4; human. [Q12851-1]
DR   CTD; 5871; -.
DR   DisGeNET; 5871; -.
DR   GeneCards; MAP4K2; -.
DR   H-InvDB; HIX0026186; -.
DR   HGNC; HGNC:6864; MAP4K2.
DR   HPA; HPA007330; -.
DR   MIM; 603166; gene.
DR   neXtProt; NX_Q12851; -.
DR   OpenTargets; ENSG00000168067; -.
DR   PharmGKB; PA30610; -.
DR   eggNOG; KOG0576; Eukaryota.
DR   eggNOG; ENOG410XP9G; LUCA.
DR   GeneTree; ENSGT00810000125351; -.
DR   HOGENOM; HOG000230824; -.
DR   HOVERGEN; HBG036702; -.
DR   InParanoid; Q12851; -.
DR   KO; K04414; -.
DR   OMA; AWATMKQ; -.
DR   OrthoDB; EOG091G022R; -.
DR   PhylomeDB; Q12851; -.
DR   TreeFam; TF105121; -.
DR   SignaLink; Q12851; -.
DR   SIGNOR; Q12851; -.
DR   GeneWiki; MAP4K2; -.
DR   GenomeRNAi; 5871; -.
DR   PRO; PR:Q12851; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000168067; -.
DR   CleanEx; HS_GCK; -.
DR   CleanEx; HS_MAP4K2; -.
DR   ExpressionAtlas; Q12851; baseline and differential.
DR   Genevisible; Q12851; HS.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0000139; C:Golgi membrane; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0008349; F:MAP kinase kinase kinase kinase activity; IEA:InterPro.
DR   GO; GO:0031435; F:mitogen-activated protein kinase kinase kinase binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0004702; F:signal transducer, downstream of receptor, with serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0007257; P:activation of JUN kinase activity; IDA:UniProtKB.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:UniProtKB.
DR   GO; GO:0007254; P:JNK cascade; TAS:ProtInc.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0006903; P:vesicle targeting; IEA:Ensembl.
DR   InterPro; IPR001180; CNH_dom.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR021160; MAPKKKK.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   Pfam; PF00780; CNH; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF038172; MAPKKKK; 1.
DR   SMART; SM00036; CNH; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50219; CNH; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell membrane; Complete proteome;
KW   Cytoplasm; Golgi apparatus; Immunity; Innate immunity; Kinase;
KW   Membrane; Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Stress response; Transferase;
KW   Ubl conjugation.
FT   CHAIN         1    820       Mitogen-activated protein kinase kinase
FT                                kinase kinase 2.
FT                                /FTId=PRO_0000086275.
FT   DOMAIN       16    273       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      482    793       CNH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00795}.
FT   NP_BIND      22     30       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION      294    314       PEST1.
FT   REGION      344    360       PEST2.
FT   REGION      405    448       PEST3.
FT   ACT_SITE    136    136       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   BINDING      45     45       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     328    328       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     394    394       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     426    433       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054134.
FT   CONFLICT    120    120       A -> R (in Ref. 4; AAA20968).
FT                                {ECO:0000305}.
SQ   SEQUENCE   820 AA;  91556 MW;  A59C1E99BFFAEF41 CRC64;
     MALLRDVSLQ DPRDRFELLQ RVGAGTYGDV YKARDTVTSE LAAVKIVKLD PGDDISSLQQ
     EITILRECRH PNVVAYIGSY LRNDRLWICM EFCGGGSLQE IYHATGPLEE RQIAYVCREA
     LKGLHHLHSQ GKIHRDIKGA NLLLTLQGDV KLADFGVSGE LTASVAKRRS FIGTPYWMAP
     EVAAVERKGG YNELCDVWAL GITAIELGEL QPPLFHLHPM RALMLMSKSS FQPPKLRDKT
     RWTQNFHHFL KLALTKNPKK RPTAEKLLQH PFTTQQLPRA LLTQLLDKAS DPHLGTPSPE
     DCELETYDMF PDTIHSRGQH GPAERTPSEI QFHQVKFGAP RRKETDPLNE PWEEEWTLLG
     KEELSGSLLQ SVQEALEERS LTIRSASEFQ ELDSPDDTMG TIKRAPFLGP LPTDPPAEEP
     LSSPPGTLPP PPSGPNSSPL LPTAWATMKQ REDPERSSCH GLPPTPKVHM GACFSKVFNG
     CPLRIHAAVT WIHPVTRDQF LVVGAEEGIY TLNLHELHED TLEKLISHRC SWLYCVNNVL
     LSLSGKSTHI WAHDLPGLFE QRRLQQQVPL SIPTNRLTQR IIPRRFALST KIPDTKGCLQ
     CRVVRNPYTG ATFLLAALPT SLLLLQWYEP LQKFLLLKNF SSPLPSPAGM LEPLVLDGKE
     LPQVCVGAEG PEGPGCRVLF HVLPLEAGLT PDILIPPEGI PGSAQQVIQV DRDTILVSFE
     RCVRIVNMQG EPTATLAPEL TFDFPIETVV CLQDSVLAFW SHGMQGRSLD TNEVTQEITD
     ETRIFRVLGA HRDIILESIP TDNPEAHSNL YILTGHQSTY
//
